Whether teen suicide and anti-depressant drugs are related has been presented as a “controversial subject” by the psychiatric industry. But earlier this year the Telegraph of London squashed psychiatry’s apparent uncertainty.
“Antidepressants can raise the risk of suicide, the biggest ever review has found, as pharmaceutical companies were accused of failing to report side-effects and even deaths linked to the drugs.
“An analysis of 70 trials of the most common antidepressants – involving more than 18,000 people – found they doubled the risk of suicide and aggressive behaviour in under 18s.” 1
Shining the Light on Truth
Nordic Cochrane Center researcher Professor Peter Gotzsche who conducted this study was sickened by the results. He states, “It is absolutely horrendous that they have such disregard for human lives.” 2
In a BMJ (British Medical Journal) report, Professor Gotzsche unfailingly takes on the psychiatric profession. When the Cochrane editors accused Professor Gotzsche of “being extreme”, he retorted:
“Usually, people who are extreme are few in number but in this case, it is the vast majority of psychiatrists that are extreme. It is truly extreme that psychiatrists have built their specialty on a number of myths, lies and highly flawed research, which have harmed our nations to the extent we have seen. Marcia Angell [previously editor-in-chief of the New England Journal of Medicine] has noted that psychiatrists should consider that other medical specialists, unlike psychiatrists, would be very reluctant to offer long-term symptomatic treatment without knowing what lies behind the symptoms, e.g. if a patient suffers from nausea or headache” 3
It is noteworthy that Professor Gotzsche’s study findings were analyzed and then endorsed by the University College London in a British Medical Journal editorial.
A Web of Lies
Big Pharma and Psychiatry were caught in a web of lies, as evidenced by the study.
For instance, 4 deaths had been untruthfully reported by a pharmaceutical company as having occurred after drug trials had ended. In another case, a patient on the antidepressant venlafaxine (brand name: Effexor) strangled himself while on the drug trial. Because he didn’t actually die for 5 more days, it was claimed he was no longer on the trial.
Drug giant Eli Lilly falsely recorded that half of the suicide attempts and suicidal ideations were merely “emotional instability or worsening of depression.”
Meanwhile, the death toll continued to rise.
In January 2016 when the Telegraph article was published, the author reported 35 inquests of deaths linked to antidepressants just that month. Staggeringly, the year before 450 inquests of this kind had been initiated. 4
A National Center for Health Research publication states that “studies showed that children and adolescents taking antidepressants were almost twice as likely to have suicidal thoughts or to attempt suicide, compared to patients taking a sugar pill.”
Antidepressant risk for children was so apparent, that in the fall of 2004 the FDA issued a warning that these drugs could lead to increased suicidal thought and behavior. 5
Psychiatrists, with their Russian roulette-like diagnostic procedures have exposed themselves as sham artists. While we can brush off with good humor the snake oil salesmen of 120 years ago, today’s version (the modern psychiatrist) offers little to laugh about. 6